Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance by unknown
RESEARCH Open Access
Splenic T1-mapping: a novel quantitative
method for assessing adenosine stress
adequacy for cardiovascular magnetic
resonance
Alexander Liu1, Rohan S. Wijesurendra1, Rina Ariga1, Masliza Mahmod1, Eylem Levelt1, Andreas Greiser2,
Mario Petrou3, George Krasopoulos3, John C. Forfar4, Rajesh K. Kharbanda4,5, Keith M. Channon5, Stefan Neubauer1,
Stefan K. Piechnik1 and Vanessa M. Ferreira1*
Abstract
Background: Perfusion cardiovascular magnetic resonance (CMR) performed with inadequate adenosine stress
leads to false-negative results and suboptimal clinical management. The recently proposed marker of adequate
stress, the “splenic switch-off” sign, detects splenic blood flow attenuation during stress perfusion (spleen appears
dark), but can only be assessed after gadolinium first-pass, when it is too late to optimize the stress response.
Reduction in splenic blood volume during adenosine stress is expected to shorten native splenic T1, which may
predict splenic switch-off without the need for gadolinium.
Methods: Two-hundred and twelve subjects underwent adenosine stress CMR: 1.5 T (n = 104; 75 patients, 29
healthy controls); 3 T (n = 108; 86 patients, 22 healthy controls). Native T1spleen was assessed using heart-rate-
independent ShMOLLI prototype sequence at rest and during adenosine stress (140 μg/kg/min, 4 min, IV) in 3
short-axis slices (basal, mid-ventricular, apical). This was compared with changes in peak splenic perfusion signal
intensity (ΔSIspleen) and the “splenic switch-off” sign on conventional stress/rest gadolinium perfusion imaging.
T1spleen values were obtained blinded to perfusion ΔSIspleen, both were derived using regions of interest carefully
placed to avoid artefacts and partial-volume effects.
Results: Normal resting splenic T1 values were 1102 ± 66 ms (1.5 T) and 1352 ± 114 ms (3 T), slightly higher than in
patients (1083 ± 59 ms, p = 0.04; 1295 ± 105 ms, p = 0.01, respectively). T1spleen decreased significantly during adenosine
stress (mean ΔT1spleen ~ −40 ms), independent of field strength, age, gender, and cardiovascular diseases. While ΔT1spleen
correlated strongly with ΔSIspleen (rho = 0.70, p < 0.0001); neither indices showed significant correlations with conventional
hemodynamic markers (rate pressure product) during stress. By ROC analysis, a ΔT1spleen threshold of ≥ −30 ms during
stress predicted the “splenic switch-off” sign (AUC 0.90, p < 0.0001) with sensitivity (90%), specificity (88%), accuracy (90%),
PPV (98%), NPV (42%).
Conclusions: Adenosine stress and rest splenic T1-mapping is a novel method for assessing stress responses,
independent of conventional hemodynamic parameters. It enables prediction of the visual “splenic switch-off” sign
without the need for gadolinium, and correlates well to changes in splenic signal intensity during stress/rest perfusion
imaging. ΔT1spleen holds promise to facilitate optimization of stress responses before gadolinium first-pass perfusion CMR.
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Background
Adenosine stress perfusion cardiovascular magnetic res-
onance (CMR) accurately detects myocardial ischemia
and guides clinical decision-making [1, 2]. However, perfu-
sion CMR has a reported false-negative rate of between 5
and 16% [2–4], which may lead to suboptimal manage-
ment strategies. In the absence of poor image quality, in-
adequate adenosine stress response is the commonest
cause of false-negative perfusion scans [4], because con-
ventional hemodynamic markers of stress response, such
as heart rate and systolic blood pressure, are unreliable
predictors of myocardial vasodilatation and the achieve-
ment of maximal hyperemia [5].
Recently, the “splenic switch-off” sign was proposed as
a CMR marker of adequate adenosine stress. It describes
visually reduced splenic perfusion during stress imaging
(spleen appears dark) compared to rest imaging (spleen
appears bright) [6], and in retrospective analyses, failed
splenic switch-off was more commonly observed in
false-negative perfusion scans than true-negatives [6].
The physiological basis for this phenomenon is that
splenic blood volume reduces significantly during exer-
cise, due to splanchnic blood redistribution [7, 8], and
can manifest as splenic “disappearance” on nuclear im-
aging [9]. The degree of splenic blood volume reduction
is proportional to exercise workload [7], independent of
cardiac output [7], and is related to adenosine-mediated
splenic vasoconstriction [10, 11]. More recently, splenic
switch-off has been shown to relate to higher myocar-
dial T2 values during dipyridamole stress, further sug-
gesting a connection between splenic and myocardial
vascular biology [12].
A key limitation of splenic switch-off is that it can only
be assessed after gadolinium first-pass perfusion imaging
[6], at which point it is too late to optimize stress ad-
equacy [13]. Repetition of inadequately stressed images
would require a wait-period (10–15 min) for gadolinium
“wash-out” from the LV cavity to optimize myocardial-
blood contrast during the subsequent (no longer first-
pass) stress perfusion imaging, leading to longer scan
durations, and exposes patients to additional adenosine
and contrast agents [6]. Therefore, a method which can
determine stress adequacy and offer opportunities for
pre-emptive stress response optimization before gadolin-
ium first-pass perfusion imaging is highly desirable.
Native T1-mapping enables quantitative characterization
of tissue blood volumes without the need for gadolinium-
based contrast agents (GBCA) [14–16], and offers the po-
tential to assess stress responses before GBCA first-pass
perfusion. T1 (proton spin-lattice) relaxation time is a
magnetic property of tissues measured in milliseconds
[14], and each tissue type, including the spleen, has its
own normal range of T1 values [14]. T1 is sensitive to
changes in tissue water content or blood volume [15–19],
and we recently showed that normal myocardial T1 in-
creases by 6% during adenosine vasodilatory stress, due to
expansions in myocardial blood volume [15, 16]. Further-
more, stress-T1 appears sensitive to changes in normal, is-
chemic and infarcted myocardium, without the need for
GBCA [15]. Contrary to its vasodilatory effects in the
myocardium, adenosine causes splenic vasoconstriction, re-
ducing the splenic blood volume, and thus expected to
lower the splenic T1 (T1spleen). Conveniently, the spleen is
typically visible on stress perfusion CMR and can be
inspected without additional planning.
This study sought to evaluate stress and rest T1spleen
as a gadolinium-free CMR marker of adenosine stress
responses by comparing with the existing “splenic
switch-off” sign and hemodynamic markers. We hypoth-
esized that: (i) T1spleen will decrease significantly from
resting values during adenosine stress, due to splenic
blood volume reductions and; (ii) stress-related changes
in T1spleen (ΔT1spleen) correlate to changes in splenic
perfusion on CMR (the “splenic switch-off” sign), but
without the need for GBCA.
Methods
All study procedures received favourable opinions from
local ethics committees, and all subjects gave written in-
formed consent.
Study population
To establish the relationship between T1spleen and splenic
perfusion/switch-off, retrospective analysis was performed
on CMR scans of 212 subjects; 104 subjects had CMR at
1.5 T (Magnetom Avanto, Siemens Healthcare, Erlangen,
Germany) and 108 subjects had CMR at 3 T (Magnetom
Trio a Tim system, Siemens Healthcare, Erlangen, Germany).
The 1.5 T population had 75 patients (n= 36 known coron-
ary artery disease [CAD], n= 39 Atrial Fibrillation [AF]) and
29 healthy controls; the 3 T population had 86 patients (n=
22 known CAD, n= 23 Type II Diabetes Mellitus [DM], n=
21 Severe Aortic Stenosis [AS], n= 20 Hypertrophic Cardio-
myopathy [HCM]) and 22 healthy controls. Healthy controls
had no history of cardiovascular disease, were not on regular
medications, and had normal electrocardiograms.
CMR protocol
All subjects avoided adenosine antagonizers (e.g. caffeine)
for ≥24 h before CMR. T1-mapping was performed using
the Shortened Modified Look-Locker Inversion recovery
(ShMOLLI) prototype sequence (WIP 561 and 448C) with
inline map generation, which uses 9-heartbeats breath-
holds per T1-map acquisition and enables on-screen
image reconstruction within 10 s [14].
Native T1-maps were acquired at rest and during peak
adenosine stress (140 μg/kg/min, 4 min, IV) in short-axis
(basal, mid-ventricular, apical) slices, followed immediately
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by first-pass perfusion imaging on matching slices during
peak stress, with an IV bolus of GBCA (0.03 mmol/kg at
6 ml/s; Dotarem, Guerbet, Villepinte, France) and saline
flush (15 ml at 6 ml/s) [15, 16]. Matching rest perfusion
images were acquired >15 min after stress perfusion and
adenosine discontinuation to allow sufficient time for con-
trast washout [15, 16].
T1-mapping analysis
Separate data files containing all T1-maps were cre-
ated and anonymized before analysis by an observer
(>3 years of T1-mapping analysis experience) blinded
to perfusion images and clinical information. T1-maps
were excluded from analysis if the spleen was not
clearly visible (2%), had respiratory-motion artefacts
on raw Inversion-Recovery-weighted images (3%) or
had suboptimal goodness-of-fit R2-maps (2%) [17, 20].
Overall, 738 T1-maps were included in final analysis,
using dedicated in-house software MC-ROI (pro-
grammed by S.K.P. in IDL, version 6.1, Exelis Visual
Information Solutions, Boulder, Colorado) [14–18,
20]. To estimate mean native T1spleen, regions of
interest (ROIs) were manually placed on T1-maps to
include as much splenic tissue as possible, avoiding
partial volume effects from large splenic blood vessels
and borders with neighbouring tissues (Fig. 1). ROIs
were quality checked against corresponding Inversion-
Recovery-weighted images and R2-maps. To derive
thresholds suitable for direct application on the CMR
console, splenic T1-reactivity to adenosine stress
(ΔT1spleen) was expressed in absolute terms: ΔT1spleen
(ms) = StressT1spleen – RestT1spleen.
T1spleen intra-scan variability assessments
Inter-slice variability in resting T1spleen, stress T1spleen
and ΔT1spleen were assessed in cases where matching
stress and rest T1-maps were performed in ≥2 different
short-axis slice positions. To assess for intra-slice
T1spleen variability, we re-analyzed healthy-volunteers
data from the original ShMOLLI methods paper, where
T1-maps were repeated >15 min apart in the same
short-axis slice within the same scan [14]. Intra-scan
variability was calculated as the standard deviation of
differences-from-the-mean in each individual.
Splenic perfusion analysis
Splenic first-pass perfusion was analysed by an observer
(>4 years of perfusion imaging analysis experience)
blinded to T1-maps and clinical information, using
CMR42 software (Circle Cardiovascular Imaging Inc.,
Calgary, Canada). Splenic ROIs were placed on stress
and rest perfusion images with frame-by-frame manual
Fig. 1 Representative stress and rest splenic first-pass gadolinium perfusion and native T1-maps. Signal intensity (SI) curves represent splenic
perfusion SI (y-axis, arbitrary units) over time (x-axis, 50–60 s). The maximum and minimum SIspleen are as indicated. Splenic regions of interests on
perfusion images and T1-maps are outlined in red and black, respectively. Mean native T1spleen and stress changes (ΔT1spleen) are as labelled.
3 T images were used for illustration (observed ΔT1spleen and ΔSIspleen are field strength independent)
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correction for artefacts and respiratory motion, to gen-
erate curves showing mean splenic signal intensity (SI,
arbitrary units) changes over time (50–60s). Peak
splenic perfusion SI (SIspleen) was estimated as the nu-
merical difference between baseline-SI and maximal-SI
during splenic first-pass perfusion as previously de-
scribed [6]. Adenosine-induced changes in SIspleen com-
pared to rest were expressed in percentages: ΔSIspleen
(%) = (StressSIspleen – RestSIspleen) ÷ RestSIspleen × 100%.
Splenic switch-off on perfusion imaging was visually
assessed by 2 independent observers (>3 years clinical
CMR perfusion experience). In the 5/212 cases where
the 2 observers disagreed, adjudication was sought from
a 3rd independent observer (Fig. 1). Perfusion images
were graded as previously described [6]: either displaying
splenic switch-off (the spleen on rest imaging is clearly
brighter than on stress imaging), or no switch-off (the
spleen on rest imaging is of similar brightness compared
to stress imaging).
Statistical analysis
Data are reported as mean ± SD, tests are 2-tailed and
parametric, based on Kolmogorov-Smirnov normality-
checks. Differences in individual characteristics were
tested using Student’s t-tests, paired within individuals
(e.g. stress vs rest T1spleen) and unpaired between
groups (e.g. ΔT1spleen in controls vs patients). Com-
parisons between ≥3 data groups were assessed using
analysis of variance (ANOVA) with Bonferroni-
corrected post-hoc method. Linear correlations were
assessed using Pearson’s correlation coefficient (R)
and non-linear correlations were assessed using
Spearman’s rank correlation coefficient (rho). Intra-
scan variability and inter-observer reproducibility of
rest/stress T1spleen and ΔT1spleen were assessed using
the Intra-class correlation coefficient (ICC), reporting
95% confidence intervals. The performance of
ΔT1spleen for replicating splenic switch-off was
assessed using receiver-operating characteristics
(ROC) curves [21], reporting area-under-the-curve
(AUC ± SEM), and also sensitivity, specificity, diagnos-
tic accuracy, positive predictive values (PPV) and
negative predictive values (NPV), with 95% confidence
intervals (CI). All analyses were performed on single
measures per-subject, using MedCalc 12.7.8 (MedCalc




Subject characteristics are summarised in Table 1. All
subjects experienced at least one adenosine-related
symptoms (e.g. chest-tightness, dyspnoea, flushing) [13],
and >10 bpm increase in heart rate (HR) during
adenosine stress, compared to rest. Significant blood
pressure response (>10 mmHg SBP decrease during
stress) was observed in 50% of subjects.
Mean stress HR was lower in 1.5 T patients compared
to other subjects, despite similar resting HR, likely due
to more frequent beta-blocker and non-dihydropyridine
calcium channel antagonist administration in these pa-
tients (all AF/CAD, Table 1).
Stress and rest T1spleen in controls and patients
In healthy controls, mean resting T1spleen values were 1102
± 66 ms (1.5 T) and 1352 ± 114 ms (3 T), which decreased
significantly during adenosine stress at 1.5 T (ΔT1spleen:
−40 ± 25 ms, p < 0.0001) and 3 T (ΔT1spleen: −43 ± 31 ms,
p < 0.0001). Patients had slightly lower resting T1spleen com-
pared to controls at 1.5 T (1083 ± 59 ms vs. 1102 ± 66 ms,
p = 0.04), and this pattern was more pronounced at 3 T
(1295 ± 105 ms vs. 1352 ± 114 ms, p = 0.01). Despite these
observed resting T1spleen differences, ΔT1spleen was compar-
able between patients and controls, at 1.5 T (−44 ± 21 ms
vs. −40 ± 25 ms, p = 0.43) and 3 T (−44 ± 26 ms vs. −43 ±
31 ms, p = 0.93; Table 2). In controls, there was a strong
correlation between stress ΔT1spleen (mean −4.1 ± 1.5%)
and ΔT1myocardium (mean 5.9 ± 1.8%), r = −0.72, p < 0.001.
See Additional file 1 for more details.
In pooled analysis, ΔT1spleen did not appear to be signifi-
cantly affected by field strength (1.5 T vs. 3 T: −43 ± 22 ms
vs. −42 ± 27 ms, p = 0.89), gender (male vs. female: −40 ±
23 ms vs. −47 ± 28 ms, p = 0.09), age (R = 0.10, p = 0.14,
range 21–89 years) or the type of cardiovascular diseases
(1.5 T CAD −42 ± 20 ms vs. 3 T CAD −40 ± 25 ms vs. AF
−46 ± 22 ms vs. HCM −43 ± 28 ms vs. AS −43 ± 21 ms vs.
DM −43 ± 32 ms, p = 0.54). In addition, ΔT1spleen was not
significantly affected by medication in patients (supple-
mentary material in Additional file 2).
T1spleen intra-scan variability
Inter-slice intra-scan variability (assessable in 96 subjects)
was within ±19 ms for resting T1spleen, ±18 ms for stress
T1spleen, and ±10 ms for ΔT1spleen. Re-analysis of the ori-
ginal ShMOLLI cohort (spleen visible in 9/10 cases), re-
vealed an intra-slice intra-scan repeat variability of
T1spleen of ±9 ms, ICC: 0.98 (95% confidence interval 0.93
to 0.99) [14]. ΔT1spleen was derived by a second independ-
ent blinded observer in 45 subjects (20 controls; 25 pa-
tients: 5 CAD, 5 AF, 5 DM, 5 AS, 5 HCM), which yielded
an ICC of 0.87 (95% confidence interval: 0.76 to 0.93).
The Bland-Altman plot for inter-observer variability is
shown in supplementary material (Additional file 3).
Associations between splenic perfusion, T1 and rate
pressure product (RPP)
By semi-quantitative analysis, peak splenic perfusion
SI (SIspleen) decreased significantly with adenosine
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stress compared to rest, with no differences between
controls and patients, or across field strengths
(Table 3). ΔSIspleen correlated strongly with ΔT1spleen
(rho = 0.70, p < 0.0001, Fig. 2). In contrast, ΔSIspleen
and ΔT1spleen did not demonstrate significant correla-
tions with stress-induced changes in RPP (R = 0.04, p
= 0.60; R = 0.06, p = 0.38, respectively).
Visual splenic switch-off assessment – relationships with
perfusion, quantitative T1spleen and hemodynamic
parameters
Subjects with visual splenic switch-off had greater stress
ΔSIspleen and ΔT1spleen values compared to those with
no switch-off (Table 4 and Fig. 3). In contrast, there
were no significant differences in stress-related










Rest T1spleen (ms) 1102 ± 66 1083 ± 59 0.04 1352 ± 114 1295 ± 105 0.01
Stress T1spleen (ms) 1061 ± 68 1039 ± 55 0.02 1308 ± 114 1253 ± 112 0.01
ΔT1spleen (ms) −40 ± 25 −44 ± 21 0.43 −43 ± 31 −44 ± 26 0.93
ΔT1spleen = StressT1spleen – RestT1spleen













Age (years) 54 ± 17 65 ± 9* 43 ± 12 60 ± 14*
Men (%) 21 (72) 58 (77) 13 (59) 58 (67)
Body mass index (kg/m2) 25 ± 4 28 ± 5 26 ± 3 28 ± 4
Hematocrit 0.42 ± 0.03 0.43 ± 0.03 0.42 ± 0.04 0.42 ± 0.03
CMR hemodynamic data
Rest HR (bpm) 66 ± 11 62 ± 15 62 ± 12 65 ± 10
Stress HR (bpm) 96 ± 15 79 ± 15* 95 ± 12 91 ± 14
Rest SBP (mmHg) 133 ± 21 139 ± 19 127 ± 14 136 ± 19
Stress SBP (mmHg) 127 ± 19 133 ± 19 122 ± 16 126 ± 19
Rest RPP (bpm.mmHg) 8800 ± 2200 8600 ± 2200 7600 ± 1700 8700 ± 2000
Stress RPP (bpm.mmHg) 12,200 ± 2600 10,500 ± 2500* 12,000 ± 2200 11,700 ± 2700
Adenosine symptoms 29 (100) 75 (100) 22 (100) 86 (100)
Co-morbidities
Current smoker 3 (10) 2 (3) 2 (9) 12 (14)
Ex-smoker 3 (10) 21 (28) 3 (14) 21 (24)
Hypertension - 28 (37) - 24 (28)
Hyperlipidemia - 23 (31) - 23 (27)
Stroke/TIA - 2 (3) - 2 (2)
Medications
Aspirin - 36 (48) - 35 (41)
Beta-blocker - 34 (45)# - 19 (22)
ACEi/ARB - 36 (48) - 39 (45)
Statin - 31 (41)# - 44 (51)
Nitrates - 3 (4) 4 (5)
CCB (non-DHP) - 13 (17)# - 0 (0)
CCB (DHP) 4 (5) 7 (8)
Values are n (%) or mean ± SD
Abbreviations: RPP rate pressure product, TIA transient ischemic attack, ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers,
CCB calcium channel antagonist, DHP dihydropyridine
*p < 0.05 compared to controls of corresponding field strength (1.5 T or 3 T). #p < 0.05 for comparisons between patient groups (1.5 T vs 3 T)
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haemodynamic changes (HR, SBP, RPP) between sub-
jects with splenic switch-off and no switch-off (Table 4
and Fig. 3).
ROC analysis of native ΔT1spleen for replicating
gadolinium-based “splenic switch-off”
ROC analysis using visual splenic switch-off as refer-
ence standard (true positives = splenic switch-off, true
negatives = no switch-off) yielded an AUC of 0.90 ± 0.05
(p < 0.0001, Fig. 4). A ΔT1spleen threshold of ≥ −30 ms dur-
ing adenosine stress replicated visual splenic switch-off
with a sensitivity of 90% (95% CI: 85–94%, p < 0.0001),
specificity 88% (95% CI: 62–98%, p < 0.0001), diagnostic
accuracy 90% (95% CI: 84–96%, p < 0.0001), PPV 98%
(95% CI: 96–100%, p < 0.0001) and NPV 42% (95% CI:
26–61%, p < 0.0001).
Discussion
This proof of principle study demonstrated that T1spleen
decreases significantly during adenosine stress compared
to baseline. The magnitude of the stress-induced T1spleen
response (ΔT1spleen) is strongly correlated with splenic
perfusion attenuation (ΔSIspleen). From a clinical view-
point, a native ΔT1spleen threshold of ≥ −30 ms accur-
ately replicated the “splenic switch-off” sign with a high
positive predictive value of 98% and offers the potential
to assess adenosine stress adequacy before GBCA first-
pass perfusion imaging. From a practical viewpoint, as-
sessment of T1spleen takes ~30 s (Fig. 5), which means it
can be repeated as necessary “on-the-fly”, to guide ad-
enosine dosage up-titrations and optimize stress re-
sponses before injection of contrast agents (example
protocol in Fig. 5). This pre-gadolinium approach may
be advantageous over the retrospective and potentially
gadolinium dose-sensitive splenic switch-off method for
improving the quality of stress responses before first-
pass perfusion imaging, which deserves further investi-
gation in future studies to determine whether it de-
creases the number of false negative perfusion scans [6].
Stress/rest T1spleen as a marker of adenosine stress
response
Patients had lower resting native T1spleen values com-
pared to controls. This may be related to the presence of
co-morbidities in patients, such as hypertension and per-
ipheral vascular disease, which may induce peripheral
vasoconstriction, with expected reductions in resting
organ blood volumes and T1spleen values. This observation
deserves further investigation in larger future studies. Na-
tive T1-relaxation times of tissues are prolonged by in-
creased blood volume (i.e. water content) [14, 15, 22].
Adenosine causes splenic artery vasoconstriction and
Table 3 Peak splenic perfusion signal intensity (SIspleen) at rest











Rest SIspleen (au) 26 ± 8 24 ± 11 29 ± 13 27 ± 13 0.16
Stress SIspleen (au) 11 ± 5 11 ± 5 13 ± 12 12 ± 8 0.10
ΔSIspleen (%) −58 ± 23 −54 ± 22 −56 ± 28 −52 ± 30 0.51
Abbreviations: Au arbitrary units
P-values derived using ANOVA with Bonferroni post-hoc method
Fig. 2 Correlation between stress-induced reductions in peak splenic signal intensity (ΔSIspleen) and splenic native T1 (ΔT1spleen). Pooled data of
controls and patients at 1.5 T (blue) and 3 T (red), represented on per-subject basis (n = 212). Spearman’s rank correlation coefficient
(Rho) = 0.70, p < 0.0001
Liu et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:1 Page 6 of 10
reduced blood volume [6–11], which shortens splenic
T1-relaxation times. This is supported by our observa-
tion of significantly lower T1spleen during adenosine
stress compared to rest, in both controls and patients.
The stress ΔT1spleen was not significantly affected by
different field strengths, age, gender and cardiovascular
diseases, likely reflecting reproducible T1-estimations
in this study [14, 15, 22].
The correlation between stress ΔT1spleen and ΔT1myo-
cardium in normal controls suggests the vasoconstrictor
effect of adenosine on the spleen is associated with vaso-
dilatory effects in the myocardium. For the relationship
between myocardial and splenic stress T1 in patients
with cardiovascular disease, larger ongoing studies will
offer reference ranges for ΔT1 in disease, and resolve
the separate effects of regional myocardial differences
and medication on stress T1 reactivity.
The observed strong correlation between ΔT1spleen
and ΔSIspleen suggests that stress-induced changes in
splenic blood volume are related to blood flow, which is
regulated by alterations in the adenosine-mediated
splenic arterial tone [10, 11]. The lack of significant cor-
relation between ΔSIspleen or ΔT1spleen with rate pressure
product is consistent with existing evidence showing dis-
sociation between imaging and hemodynamic markers
of stress response [5, 6], and further suggests that stress
responses during clinical CMR cannot be reliably
assessed using hemodynamic observations alone [5].
This deserves further investigation.
A threshold of ≥30 ms decrease in T1spleen replicated
complete splenic switch-off with a high positive predict-
ive value of 98%. The intra-scan variability in T1spleen
(inter-slice: ±10 ms; intra-slice: ±9 ms) was 3-times less
than this proposed threshold ≥30 ms drop, with excel-
lent T1-fit as evident on quality control R2-maps, despite
the lack of dedicated image optimization (e.g. shimming)
over the spleen. For stress T1spleen responses <30 ms,
further work is needed to determine whether adenosine
dose-increments or waiting longer with the same infu-
sion rate may improve the confidence of stress re-
sponses, and impact on diagnostic performance of stress
CMR for the diagnosis of ischemia.
Limitations and future directions
This proof-of-concept study is based on ShMOLLI
T1spleen values derived from short-axis slices planned for
myocardial perfusion CMR imaging; the spleen was not
visible in a small proportion of T1-maps (~2%), and fu-
ture applications of splenic T1-mapping may benefit
Table 4 Stress-induced changes in peak splenic perfusion signal
intensity (ΔSIspleen), T1 (ΔT1spleen) and hemodynamic parameters






All subjects n = 212 196 (92) 16 (8) -
Healthy volunteers n = 51 49 (96) 2 (4) -
Patients n = 161 147 (91) 14 (9) -
ΔSIspleen (%) −62 ± 17 17 ± 29 <0.0001
ΔT1spleen (ms) −46 ± 22 −2 ± 25 <0.0001
Stress hemodynamic changes
Δ heart rate (bpm) 19 ± 9 20 ± 12 0.83
Δ SBP (mm. Hg) −8 ± 22 −10 ± 19 0.76
Δ RPP (bpm.mmHg) 2800 ± 2100 2600 ± 1700 0.89
Values are n (%) or mean ± SD



















































































Fig. 3 Relations between different markers of stress adequacy. Subjects with the “splenic switch-off” sign had greater stress-induced reductions in
a gadolinium-based splenic perfusion (ΔSIspleen, same technique) and b gadolinium-free splenic T1 (ΔT1spleen, different technique) compared to
subjects with no switch-off. There was no difference in stress-induced c hemodynamic changes in rate pressure product (RPP) between the splenic
switch-off and the no switch-off subjects. Data are mean ± 1SD
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from a dedicated image planned through the spleen.
Rapid on-scanner T1-map reconstructions, with the im-
mediate availability of goodness-of-fit measures (such as
R2-maps), are imperative to enable practical “on-the-fly”
repetition of reliable T1spleen estimations to guide stress
response optimization (Fig. 5). Given the overall excellent
R2-maps over the spleen and the narrow T1spleen ranges
obtained, data in this study suggest that stress/rest splenic
T1-mapping can be feasibly included in CMR protocols
without major technical adjustments. Practical in-vivo T1-
estimations are method-dependent, and demonstrate
increasingly discrepant heart rate dependencies at longer
T1-values [23]. Therefore, results achieved with
ShMOLLI, in particular the splenic T1-thresholds replicat-
ing splenic switch-off, should be interpreted with care be-
fore directly translating to other T1-mapping techniques.
Choosing methods that can withstand dynamic HR-
variations and tachycardia without significant HR-
dependencies is therefore paramount when performing
stress-T1 studies. The gadolinium-based splenic switch-
off sign is only seen with non-selective adenosine re-
ceptor agonists (dipyridamole and adenosine), but was
absent with cardio-selective vasodilators (e.g. regadeno-
son) or inotropic agents (e.g. dobutamine) [6]. Further
work is needed to elucidate stress T1spleen responses
using pharmacological agents other than adenosine and
during physical exercise. Patients in this study were un-
selected for diseases known to affect splenic blood vol-
umes, e.g. venous portal hypertension, hematological
malignancies and systemic inflammation; thus, further
studies to characterize the effects of these diseases on
T1spleen will help to determine the general applicability
of this technique. While we identified a cut-off of
≥30 ms drop in T1spleen during stress for replicating
complete splenic switch-off, the clinical utility of this
threshold for detecting true stress adequacy needs to be
validated against false-negative perfusion scans, deter-
mined by comparison to invasive coronary angiography
and pressure-wire based assessments of functional is-
chemia, such as fractional flow reserve. This is topic of
ongoing work.
Conclusions
Adenosine stress and rest splenic T1-mapping is a
novel method for assessing stress responses, independ-
ent of conventional hemodynamic parameters. It
Fig. 4 ROC curves of native ΔT1spleen for replicating the
gadolinium-based “splenic switch-off” sign. A ΔT1spleen threshold
of ≥ −30 ms replicated the “splenic switch-off” sign (AUC 0.90 ± 0.05,
p < 0.0001), with high sensitivity 90%, specificity 88% and diagnostic
accuracy 90%
Fig. 5 Potential splenic ΔT1spleen-guided protocol for real-time assessment and optimization of stress adequacy before gadolinium perfusion.
Practical T1spleen assessment using ShMOLLI typically takes around 30 s: breath-hold instructions (5 s), T1-map acquisition over 9-heart-beats
(~10 s, shorter with higher stress heart rates), on-screen image reconstruction (5–10 s), splenic-ROI placement directly on CMR console screen by
the operator (5 s) followed by immediate display of T1spleen/SD estimations (as indicated). The ability of this protocol to improve the quality of
stress responses deserves validation in future studies
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enables prediction of the visual “splenic switch-off” sign
without the need for gadolinium, and correlates well to
changes in splenic signal intensity during stress/rest
perfusion imaging. ΔT1spleen holds promise to facilitate
optimization of stress responses before gadolinium
first-pass perfusion CMR.
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